Recent progress in the treatment of acute lymphoblastic leukemia

著者

• Stock, Wendy
• Wetzler, Meir

書誌事項

Recent progress in the treatment of acute lymphoblastic leukemia

guest editors, Wendy Stock, Meir Wetzler

（Hematology/oncology clinics of North America, v. 23, no. 5）

Saunders, c2009

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BB10325884
• ISBN:
  • 9781437712278
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: Philadelphia, Pa.
• ページ数/冊数: xviii, p. [949]-1154
• 大きさ: 24 cm
• 分類:
  • NLM : WH 250
• 件名:
  • MESH : Precursor Cell Lymphoblastic Leukemia-Lymphoma -- therapy
  • LCSH : Lymphoblastic leukemia in children
• 親書誌ID:
  • BA74404928